This initiative has the potential to make a lasting impact in our communities by providing more reliable, consistent access to these life-changing medications for the millions of Americans who want a better, more affordable way to take care of their health." According to the World Health Organization (WHO), around 70% of American adults have obesity or are overweight and at least 2.8 million people die each year due to being overweight or having obesity
Liver Health: GLP-1 agonists can improve liver health, particularly concerning fatty liver disease
B12 deficiency is more common than widely recognized, particularly in individuals who follow plant-based diets, take proton pump inhibitors or metformin, are over 50, or have gastrointestinal conditions affecting absorption
In clinical trials, this dual action has demonstrated greater glycemic control and weight reduction compared to specific selective GLP-1 receptor agonists such as semaglutide 1 mg in the SURPASS-2 trial
No aumentes la dosis sin revisar la etiqueta, tolerancia digestiva, medicamentos y objetivo
Eva Kamensk